Systemic Lupus Clinical Trials in Wuhan, Hubei
14 recruitingWuhan, Hubei, China
Showing 1–14 of 14 trials
Recruiting
Phase 3
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
AbbVie1,000 enrolled369 locationsNCT05843643
Recruiting
Phase 1Phase 2
A Study of GR1803 in Systemic Lupus Erythematosus
Systemic Lupus ErthematosusAuto Immune Disease
Genrix (Shanghai) Biopharmaceutical Co., Ltd.44 enrolled1 locationNCT07348055
Recruiting
Phase 1
A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Hangzhou Qihan Biotech Co., Ltd.18 enrolled3 locationsNCT07444307
Recruiting
Phase 4
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
Interstitial Lung DiseaseLupus or SLESystemic Lupus Erythematosus
Tongji Hospital100 enrolled1 locationNCT07077486
Recruiting
Early Phase 1
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07339332
Recruiting
Early Phase 1
the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
Recurrent or Refractory Systemic Lupus ErythematosusRecurrent or Refractory IgG4 Related DiseasesRecurrent or Refractory Systemic Sclerosis+2 more
Tongji Hospital45 enrolled1 locationNCT07339540
Recruiting
Phase 1
Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07031713
Recruiting
Phase 1
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology25 enrolled2 locationsNCT06400537
Recruiting
Not Applicable
Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Tongji Hospital6 enrolled1 locationNCT06902844
Recruiting
Early Phase 1
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology34 enrolled1 locationNCT06653556
Recruiting
Phase 1Phase 2
A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology15 enrolled1 locationNCT06106906
Recruiting
Phase 1Phase 2
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology15 enrolled1 locationNCT06106893
Recruiting
Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Tongji Hospital139 enrolled1 locationNCT06458972
Recruiting
Phase 2
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Beijing InnoCare Pharma Tech Co., Ltd.186 enrolled41 locationsNCT05688696